health and safety plan solid waste management unit assessment

More documents

Recommendations

Info

AUTOMOTIVE GASOLINE 65-27 TABLE 65-4 ACUTE TOXICITY OF COMPONENTS OF AUTOMOTIVE GASOLINE Component Oral Dermal us0 LD6O u6O n-hexane octane dodecane isopentane isooctane 24-49 mL/kg [rat] (1935) 28,710 mg/lcg [rat] (1937) < < no data C no data no data no data no data 33,000 ppm 04 hr (1935) (rat] no data > > 1000 q/L [mouse] (12) > methylcyclopentane < no data '> methycyclohexane 2250 mg/kg [rat] (47) no data no data cyclohexane 29,820 mg/kg [rat] (1935) no data no data benzene toluene xylenes ethyl benzene trimethylbenzenes 1-methylnaphthalene 2-methylnaphthalene 3800 mg/kg [rat] (59) 4700 mg/kg [mouse] (47) 5000 mgjlcg [rat] (47) 4300 mg/kg [rat] (47) 3500 mg/kg [rat] (47) no data 1840 mg/kg [rat] (47) 1630 mg/kg [rat] (47) no data 10,000 ppm -7 hr [rat] (47) 12,124 [rabbit] mg/kg (47) 5320 ppm -8 hr [mouse] (47) no data 5000 ppm 04 hr [rat] (47) 5000 mg/lcg no data [rabbit] (59,) no data no data no data 18 mg/ms -4 hr [rat] (47) no data no data 6/87
AUTOMOTIVE GASOLINE 65-28 10 months in mild to moderate cases, but may take up to 3 years in serious cases. The threshold level at which neuropathy occurs has not been firmly established but symptoms have been observed in people exposed to concentrations ranging from 10 to 200 ppm for 9-12 months. In animals, signs of narcosis are seen after mice are exposed to vapor levels of 16,000 ppm for 5 minutes. Death generally occurred at concentrations between 43,800 and 52,000 ppm after 9-119 minutes. The oral Lb,, is cited as 24 mL/kg for 14-day-old rats and 49 mL/kg for young adult rats. Long-term inhalation experiments. in rats suggest that the first signs of neurotoxicity appear after they are exposed to levels of 200 ppm for 24 weeks. This higher threshold to induce neurotoxicity in animals may be due to differences in metabolism. Specifically, 2-hexanol is the chief metabolite in animals, while 2,5-hexanediona which is neurotoxic, predominates in man. Chronic topical application of a solvent containing 35.2% n-hexane caused axonal swelling and myelin degeneration in chicks. No clinical signs were seen. Dosage was 1 g/kg/day for 64 days. In rabbits, topical application of 0.5 ml/day for up to 10 days caused redness, irritation and scab formation. N-hexane is neither carcinogenic or teratogenic. One & vivo study in rats that inhaled 150 ppm for 5 days found an increased number of chromosome. aberrations in the bone marrow cells. No studies on mutagenicity, reproductive toxicity or carcinogenicity in man were found (;2,1930,1935). Isopentane is a CNS depressant. Effects may include exhilaration, dizziness, headache, loss of appetite, nausea, confusion, inability to do fine work, a persistent taste of gasoline and in extreme cases, loss of consciousness. Inhalation of up to 500 ppm appears to have no effect on humans. "Very high" vapor concentrations are irritating to the skin and eyes. Repeated or prolonged skin contact will dry and defat skin resulting in irritation and dermatitis. The LC,, in the mouse is estimated to be 1000 mg/L (12). (isohexane, 3-methylpentane) No physiological data are available but isohexanes are expected to be mucous membrane irritants and to have a low oral toxicity. Isohexanes are predicted to have narcotic properties and are documented to be cardiac sensitizers but are not expected to have neurotoxic properties (12). Cyclohexane is a CNS depressant of low toxicity. Symptoms of acute exposure are excitement, loss of equilibrium, stupor and coma. Rarely, death results due to respiratory failure. The anesthesia which is induced is weak and of brief duration but more potent than that 6/87
Page 1 and 2:
Environmental and Safety Designs, I
Page 3 and 4:
Table of Contents 1.0 2.0 3.0 4.0 5
Page 5 and 6:
1.0 INTRODUCTION The following Heal
Page 7 and 8:
3.0 SITE CHARACTERIZATION Health an
Page 9 and 10:
CAMP LEJEUNE NORTH CAROLINA I
Page 11 and 12:
Health and Safety Plan Solid Waste
Page 13 and 14:
5.0 HAZARD EVALUATION Health and Sa
Page 15 and 16:
Marine Health and Safety Plan Solid
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Health ana’ Safety Plan Solid Was
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
6.0 EMPLOYEE PROTECTION Health and
Page 47 and 48:
Page 49 and 50:
l a Standard safe operating procedu
Page 51 and 52:
7.0 TEMPERATURE EXPOSURE GUIDELINES
Page 53 and 54:
9.0 EXPOSURE EVALUATION Health and
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
12.0 SITE CONTINGENCY PLAN Health a
Page 61 and 62:
12.3 Site Resources Health and Safe
Page 63 and 64:
Page 65 and 66:
PLAN ACCEPTANCE Health and Safety P
Page 67 and 68:
Page 69 and 70:
APPENDIX A MSDS ..,~. .- _ - -__..
Page 71 and 72:
FUEL OILS 66-2 l Physical State (at
Page 73 and 74:
FUEL OILS 66-4 bIR EXPOSURE LIMITS:
Page 75 and 76:
FTJELOILS 66-6 l State Water Progra
Page 77 and 78:
FUEL OILS 66-8 66.1 MAJOR USES Fuel
Page 79 and 80:
FUELOILS 66-10 TABLE 66-2 COMMON AD
Page 81 and 82:
TABLE 66-3 EQUILIRRIUN PAPllOWlYt O
Page 83 and 84:
FUEL OILS Migration through soils m
Page 85 and 86:
PUEL OILS 66-16 relatively small fr
Page 87 and 88:
FUEL OILS 66-18 TABLE 66-4 POTENCIE
Page 89 and 90:
FUEL OILS 66-20 66.3.1.4 Other Toxi
Page 91 and 92:
FUELOILS 66-22 66.3.1.4.2 Chronic T
Page 93 and 94:
FUEL OILS 66-24 TABLE 66-5 ACUTE TO
Page 95 and 96:
FUEL OILS 66-26 Iso-octg~lf: (2,2,4
Page 97 and 98:
FUEL OILS 66-28 Ethyl benzene is pr
Page 99 and 100:
FUEL OILS 66-30 AC d Methemoglobine
Page 101 and 102:
JP-4 (JET FUEL 4) 64-1 APPROXIMATE
Page 103 and 104:
JP-4 (JET FUEL 4) 64-3 HANDLING PRE
Page 105 and 106:
JP-4 (JET FUEL 4) 64-5 REGULATORY S
Page 107 and 108:
JP-4 (JET FUEL 4) 64-7 64.1 MAJOR U
Page 109 and 110: JP-4 (JET FUEL 4) 64-9 TABLE 64-1 -
Page 111 and 112: JP-4 (JET FUEL 4) 64-11 TABLE 64-2
Page 113 and 114: JP-4 (JET FUEL 4) 64-13 solubility.
Page 115 and 116: JP-4 (JET FUEL 4) 64-15 Compared wi
Page 117 and 118: JP-4 (JET FUEL 4) 64-17 TABLE 64-5
Page 119 and 120: JP-4 (JET FUEL 4) 64-19 Although th
Page 121 and 122: JP-4 (JET FUEL 4) 64-21 Volatilizat
Page 123 and 124: JP-4 (JET NEL 4) 64-23 In tests con
Page 125 and 126: JP-4 (JET FUEL 4) headache, nausea,
Page 127 and 128: JP-4 (JET FUEL 4) 64-27 Paralysis d
Page 129 and 130: JP-4 (JET FUEL 4) 64-29 exposed to
Page 131 and 132: JP-4 (JET FUEL 4) 64-31 mg/kg and 1
Page 133 and 134: JP-4 (JET FUEL 4) 64-33 various col
Page 135 and 136: AUTOMOTIVE GASOLINE 65-2 PHYSICO- C
Page 137 and 138: AUTOMOTIVE GASOLINE 65-4 kIR EXPOSU
Page 139 and 140: AUTOMOTIVE GASOLINE 65-6 Directives
Page 141 and 142: AUTOMOTIVE GASOLINE 65-8 65.1 MAJOR
Page 143 and 144: AUTOMOTIVE GASOLINE 65-10 TABLE 65-
Page 145 and 146: AUTOMOTIVE GASOLINE 65-12 a. initia
Page 147 and 148: TABLE 65-3 EQUILIBRIUN PARflOYlYG O
Page 149 and 150: AUTOMOTIVE GASOLIt@i 65-16 Some res
Page 151 and 152: 65-18 Although the microbiota of mo
Page 153 and 154: AUTOMOTIVE GASOLINE 65-20 higher. A
Page 155 and 156: AUTOHOTIVE GASOLINE 65-22 Tests for
Page 157 and 158: AUTOMOTIVE GASOLINE 65-24 experimen
Page 159: AUTOMOTIVE GASOLINE 65-26 cancer hy
Page 163 and 164: AUTOMOTIVE GASOLINE 65-30 The trime
Page 165 and 166: AUTOMOTIVE GASOLINE 65-32 spontaneo
Page 167 and 168: AUTOMOTIVE GASOLINE 65-34 even the
Page 169 and 170: STODDARD SOLVENT 67-2 0 Log (Octano
Page 171 and 172: STODDARD SOLVENT 67-L JR EXPOSURE L
Page 173 and 174: STODDARD SOLVENT 67-6 EEC Directive
Page 175 and 176: STODDARD SOLVENT 67-8 67.1 MAJOR US
Page 177 and 178: TARLE 67-2 EQUlLlSRlUN PARlIOYIY6 O
Page 179 and 180: STODDARD SOLVENT 67-12 aliphatics,
Page 181 and 182: STODDARD SOLVENT 67-14 incidence co
Page 183 and 184: STODDARD SOLVENT 67-16 67.3.2 Human
Page 185 and 186: STODDARD SOLVENT 67-18 the site of
Page 187 and 188: STODDARD SOLVENT 67-2 l Log (Octano
Page 189 and 190: STODDARD SOLVENT 67-G RNVTRONBENTAL
Page 191 and 192: STODDARD SOLVENT 67-6 (538) Direct
Page 193 and 194: STODDARD SOLVENT 67-8 67.1 MAJOR US
Page 195 and 196: IAOLE 67-2 EQUILI~RIUI PARflOYIYG O
Page 197 and 198: STODDARD SOLVENT 67-12 aliphatics.
Page 199 and 200: STODDARD SOLVENT 67-14 incidence we
Page 201 and 202: STODDARD SOLVENT 67-16 67.3.2 Human
Page 203 and 204: STODDARD SOLVENT 67-18 the site of
Page 205 and 206: HYDRAULIC FLUID 68-2 I PERSISTENCE
Page 207 and 208: ~RALJLIC FLUID 68-32 the constituen
Page 209 and 210: HYDRAULIC FLUID 6814 REGULATORY STA
Page 211 and 212:
HYDRAULIC FLUID 68-6 Directive on T
Page 213 and 214:
TABLE 68-l 3 $ HYDRAULIC OILS 3 Fa
Page 215 and 216:
TABLE 68-l - Continued HYDRAULIC OI
Page 217 and 218:
. TABLE 68-1 - Continued HYDRAULIC
Page 219 and 220:
TABLE 68-l - Continued HYDRAULIC OI
Page 221 and 222:
HYDRAULIC FLUID 68-16 TABLE 68-2 -
Page 223 and 224:
HYDRAULIC FLUID 68-18 TABLE 68-3 SO
Page 225 and 226:
HYDRAULIC FLUID 68-20 Transport and
Page 227 and 228:
HYDRAULIC FLUID 68-22 high volatili
Page 229 and 230:
HYDRAULIC FLUID 68-24 reaction at 2
Page 231 and 232:
HYDSWJLIC FLUID 68-26 TABLE,68-4 AC
Page 233 and 234:
HYDRAULIC FLUID 68-28 transient irr
Page 235 and 236:
HYDRAULIC FLUID 68-30 BHT is mildly
Page 237 and 238:
METHYL ETHYL KETONE 41-a TABLE 41-1
Page 239 and 240:
METMYL ETHYL KETONE 41-6 EEC DfrGti
Page 241 and 242:
METHYL ETRYL KETONE 41-4 Promubted
Page 243 and 244:
METHYL ETHYL KETONE 41-2 PERSISTENC
Page 245 and 246:
MBTHYL ETHYL KETONE 41-10 ketone th
Page 247 and 248:
METHYL ETHYL KETONE 41-12 41.3.1.2
Page 249 and 250:
METHYiL ETHYL KETONE 41-14 axons in
Page 251 and 252:
METHYL ETHYL KETONE 41-16 41.3.4 Ha
Page 253 and 254:
ETHYLENE GLYCOL 43-l COMMON SYNONYM
Page 255 and 256:
ETHYLENE CLYCOL 43-3 ENVIRONMENTAL
Page 257 and 258:
ETWLENE GLYCOL 43-5 43.1 MAJOR USES
Page 259 and 260:
EIWLENE GLYCOL 43-7 Data on ethylen
Page 261 and 262:
ETHYLENE GLYCOL 43-9 animals) verte
Page 263 and 264:
ETHYLmE GLYCOL 43-11 The effect of
Page 265 and 266:
- .-.- ---_ -. _ I_T_-- ETHYLENE GL
show all

health and safety plan solid waste management unit assessment

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?